Brain

AlzeCure Publishes its Interim Report for January – September 2023

STOCKHOLM, SWEDEN / ACCESSWIRE / November 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced…

8 months ago

Neurolutions, Inc. and Kandu Health Announce Strategic Partnership to Accelerate Access to Breakthrough Brain Computer Interface (BCI) and Remote Support for Stroke Rehabilitation

Companies’ Post-Stroke Solutions Aim to Significantly Improve Recovery Journey for Patients and Their FamiliesSANTA CRUZ, Calif. & CAMPBELL, Calif.--(BUSINESS WIRE)--Neurolutions,…

8 months ago

GE HealthCare and Masimo Collaborate to Bring Masimo SET® Pulse Oximetry to the Wireless and Wearable GE HealthCare Portrait Mobile Platform

CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo…

8 months ago

As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)

Company Introduces Multimedia Resources to Bring Awareness of SADLAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving…

8 months ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

CARMEL, Ind., Nov. 08, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…

8 months ago

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

CAPE CANAVERAL, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of…

8 months ago

Masimo Announces New Member of the Board of Directors

Rolf A. Classon Joins Masimo’s Board of DirectorsIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been…

8 months ago

FSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One Basis

TORONTO, ON / ACCESSWIRE / November 7, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

8 months ago

Nomination Committee Appointed for IRLAB’s Annual General Meeting 2024

GOTHENBURG, SE / ACCESSWIRE / November 07, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, November 7, 2023 - IRLAB…

8 months ago

FSD Pharma Files Preliminary Base Shelf Prospectus to Replace Expired Base Shelf Prospectus

TORONTO, ON / ACCESSWIRE / November 6, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

8 months ago